Preimplantation Genetic Testing Market to Witness Explosive Growth, Worth USD 1800 Million By 2032 – SNS Insider

According to a SNS Insider, the global Preimplantation Genetic Testing market size was USD 791.50 million in 2023, and is projected to reach USD 1849.38 million by 2032, at a CAGR of 9.93% from 2024 to 2032. This growth is mainly due to the increasing fertility problems worldwide, the acceptance of assisted reproductive technologies (ART), and innovative developments in genetic testing technology.

Market Scenario: Focus on Reproductive Health

According to a recent report by the World Health Organization (WHO), approximately 1 in 6 people worldwide are facing fertility problems. This growing problem and the trend of family planning at a later age have led to a rapid increase in the demand for IVF treatment. PGT has become a natural step to increase the chances of IVF success and prevent hereditary genetic diseases. PGT is currently used most in North America and Europe, but the market is growing fastest in the Asia-Pacific region, especially in India, China, and Japan, due to improvements in healthcare facilities and increased awareness.

A major driver behind this growth is the advancement in technology. With the help of sophisticated methods such as Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), and Artificial Intelligence (AI), embryo quality testing has become more accurate, faster, and cheaper. Moreover, methods such as ‘non-invasive PGT’ are now being developed without performing an embryo biopsy, making the procedure even safer.

Get a Sample Report of Preimplantation Genetic Testing Market Forecast: https://www.snsinsider.com/sample-request/6298

Preimplantation Genetic Testing Market Segmentation Analysis:

• By Procedure: Preimplantation Genetic Diagnosis (PGD) segment dominated the market with nearly 78% market share in 2023. PGD is mainly used to detect hereditary genetic diseases like cystic fibrosis, sickle cell anemia, etc. in embryos.
• By Product: Reagents and other consumables accounted for more than half of the market share as these materials have to be purchased repeatedly for each IVF cycle. On the other hand, machinery usage is the fastest growing segment as the installation of modern, automated machines in clinics is increasing.
• By Technology: PCR technology is preferred due to its accuracy and low cost, which has led to a market share of 38.55%.
• By Application: Aneuploidy screening (testing for an uneven number of chromosomes) is the largest segment, as more than half of the embryos in IVF are at risk of chromosomal abnormalities, which can lead to miscarriage or disorders such as Down syndrome.
• End-use: PGT is most commonly used in fertility centers, as it is the first step in IVF treatment for most couples.

Regional Insights: North America Leads, Asia-Pacific Leads

In 2023, North America (particularly the US) dominated the global PGT market with over 40% share. This is due to the high-quality healthcare, insurance coverage for IVF procedures, and advanced genetic testing facilities.

Asia-Pacific, on the other hand, has emerged as the fastest-growing market, with a CAGR of 10.89%. Lifestyle changes, rising fertility concerns, fertility tourism, and government awareness in countries like India and China have created huge opportunities for PGT services here.

Major Players Analysis Listed in the Preimplantation Genetic Testing Market Report are

• Illumina, Inc. (Verifi Prenatal Test, TruSight NIPT Solution)
• Thermo Fisher Scientific Inc. (Ion ReproSeq PGS Kit, Ion AmpliSeq Exome RDY Kit)
• PerkinElmer Inc. (PG-Seq Rapid Non-Invasive PGT-A Kit, Vanadis NIPT System)
• Natera, Inc. (Spectrum Preimplantation Genetic Test, Panorama Non-Invasive Prenatal Test)
• The Cooper Companies Inc. (CooperSurgical PGTai, LifeGlobal Mediums)
• Invitae Corporation (Carrier Screening, Preimplantation Genetic Testing)
• Igenomix (PGT-A, PGT-M)
• Bioarray S.L. (PGT-A, PGT-M)
• Genea Limited (GeneSyte NIPT, GeneSure PGT)
• Quest Diagnostics Incorporated (QHerit Carrier Screening, QNatal Advanced)
• Laboratory Corporation of America Holdings (Integrated Genetics, Inheritest Carrier Screen)
• Agilent Technologies, Inc. (SureScan Microarray Scanner, GenetiSure Pre-Screen Kit)
• Abbott Laboratories (Reproductive Health Assays, Vysis Probes)
• QIAGEN N.V. (ReproSeq PGS Kit, QIAseq Targeted DNA Panels)
• Vitrolife (PGT-A, EmbryoScope+)
• Oxford Nanopore Technologies plc (MinION, PromethION)
• Yikon Genomics (One-Step PGT, MALBAC)
• Medicover Genetics (PGT-A, PGT-M)
• Fulgent Genetics (Carrier Screening, NGS Panels)
• Genemind Biosciences Co., Ltd. (PGT-A, PGT-M)

Purchase Single User PDF of Preimplantation Genetic Testing Market Report: https://www.snsinsider.com/checkout/6298

Recent developments:

The field of PGT is constantly entering new technologies.

In July 2023, Thermo Fisher Scientific launched two new kits for fetal chromosome testing, which will bring speed and accuracy to research.

In June 2024, QIAGEN introduced a new tool based on digital PCR technology, which can analyze genetic diseases with greater precision. Such developments show that the field is constantly changing in terms of technology and finding more effective solutions for patients.

Other Trending Reports

Orthobiologics Market

Biopharmaceutical CMO Market

Multiple Sclerosis (MS) Market

Online Pharmacy Market

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:

Rohan Jadhav - Principal Consultant

Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)

Email: info@snsinsider.com